Table 1 ScFDC1-containing whole-cell biotransformations of 1a–x: maximal conversions obtained under optimized conditions (100 mM sodium phosphate buffer pH 7.0, cells OD600 of ~1, 35 °C).

From: Exploring the substrate scope of ferulic acid decarboxylase (FDC1) from Saccharomyces cerevisiae

Substrate

t (h)

c* (%)

Eb** (kcal/mol)

LUMO (eV)

Planarity***

cinnamic acid

1a

24

>99

−6.6

1.681

1

(E)-3-(2-bromophenyl)acrylic acid

1b

48

83[a]

−6.4

1.502

0

(E)-3-(3-bromophenyl)acrylic acid

1c

8

>99

−5.9

1.305

1

(E)-3-(4-bromophenyl)acrylic acid

1d

24

>99

−5.2

1.313

1

(E)-3-(2-methoxyphenyl)acrylic acid

1e

48

92[a]

−5.9

1.579

1

(E)-3-(3-methoxyphenyl)acrylic acid

1f

48

>99

−5.5

1.638

1

(E)-3-(4-methoxyphenyl)acrylic acid

1g

72

>99

−5.7

1.376

1

(E)-3-(2-(trifluoromethyl)phenyl)acrylic acid

1h

72

62[a]

−6.2

1.212

0

(E)-3-(3-(trifluoromethyl)phenyl)acrylic acid

1i

48

87[a]

−5.0

1.170

1

(E)-3-(4-(trifluoromethyl)phenyl)acrylic acid

1j

48

82[a]

−4.3

0.931

1

(2E,4E)-5-phenylpenta-2,4-dienoic acid

1k

48

>99

−4.4

0.957

1

(E)-5-phenylpent-2-enoic acid

1l

72

<1

−5.7[c]

1.450

0

(E)-3-(naphthalen-2-yl)acrylic acid

1m

48

>99

−4.7

0.924

1

(E)-3-(quinolin-2-yl)acrylic acid

1n

8

39[b]

−2.5

0.701

0

(E)-3-(quinolin-4-yl)acrylic acid

1o

8

28[b]

−6.0

0.638

0

(E)-3-(benzofuran-2-yl)acrylic acid

1p

8

>99

−4.9

1.222

1

(E)-3-(benzofuran-3-yl)acrylic acid

1q

30

79[a]

−5.4

1.421

1

(E)-3-(5-chlorobenzofuran-2-yl)acrylic acid

1r

8

>99

−3.2

0.909

1

(E)-3-([1,1′-biphenyl]-4-yl)acrylic acid

1s

30

59[a]

−3.8

0.822

0

(E)-3-(4′-fluoro-[1,1′-biphenyl]-4-yl)acrylic acid

1t

48

70[a]

−3.7

0.775

0

(E)-3-(5-phenylthiophen-2-yl)acrylic acid

1u

72

85[a]

−3.2

0.654

0

(E)-3-(5-(4-bromophenyl)furan-2-yl)acrylic acid

1v

72

<1

−3.6[d]

0.556

1

(E)-3-(2-phenylthiazol-4-yl)acrylic acid

1w

72

<1

−2.8[c]

0.429

1

(E)-3-(10-methyl-10H-phenothiazin-2-yl)acrylic acid

1x

72

<1

[e]

1.059

0

  1. [a]Complete conversion reached after additional 24 h reaction time with fresh cell batch; [b]no conversion increase after additional 24 h reaction time with fresh cell batch; [c]unfavourable binding pose of the acrylic double bond related to the prFMN cofactor; [d]unfavourable, reverse binding pose – the substrate’s carboxyl group located distant from R175; [e]positioning within the catalytic site was not found, substrate binding occurs in a surface pocket close to the catalytic site; *Determined through monitoring the substrate depletion by HPLC; **Eb – binding energy; ***1 indicates planar structure of substrate and 0 otherwise.